Human CXCL10/IP-10 Quantikine ELISA Kit DIP100 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemHuman CXCL10/IP-10 Quantikine ELISA Kit
CompanyR&D Systems, a Bio-Techne Brand
Price $680.00Supplier Page View Company Product Page
Catalog NumberDIP100
Quantity1 Kit (also 1 Pack (50 Plates), 1 Pack (6 Plates))
ApplicationsELISA
Detection Range7.81 - 500 pg/mL
ReactivityHuman
Sample TypeCell Culture Supernates (10 uL), Serum (75 uL), EDTA Plasma (75 uL), Heparin Plasma (75 uL), Saliva (10 uL), Urine (100 uL)
Sensitivity4.46 pg/mL
Detection TargetCXCL10/IP-10/CRG-2
Assay Time4.5 hours
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
NCBI Full Gene NameC-X-C motif chemokine ligand 10
NCBI Gene AliasesC7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) 3D pentaculture model unveils malignant cell-driven macrophage polarization in high-grade serous ovarian cancerNat CommunMarch 25, 2026Beatrice Malacrida, Samar Elorbany, Florian Laforêts, Faisal Karim, Rachel C. Bryan-Ravenscroft, Michail Sideris, Joash D. Joy, Panoraia Kotantaki, Sophie L. P. Skingsley, Owen M. Heath, et al.debris and subsequently stored at -80C until use. ELISA was used to quantify CXCL10 (Bio-Techne, Cat. DIP100) and CCL4 (Bio-Techne, Cat. DMB00) according to manufacturer’s protocol. ELISA plates were read using

(2) Integration of intragraft transcriptomics and urinary cytokines identifies CXCL10 and FasL signature in subclinical acute rejectionScientific ReportsFebruary 19, 2026Sharon Natasha Cox, Samantha Chiurlia, Emanuela Pasculli, Luigi Biancone, Davide Diena, Vincenzo Cantaluppi, Andrea Airoldi, Ilaria Gandolfini, Umberto Maggiore, Nicola Bossini, et al.MBS9322325), CD247 (MyBioSource, Cat. No. MBS773629), CXCL10 (R&D Systems Quantikine ELISA Kit, Cat. No. DIP100), and FasL (TNFSF6, R&D Quantikine® ELISA, Cat. No. DFL00B) were quantified using commercially available

(3) CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancerJournal of Clinical InvestigationFebruary 2, 2026Fabiana Napolitano, Yunguan Wang, Dhivya R. Sudhan, Paula I. Gonzalez-Ericsson, Luigi Formisano, Nisha Unni, Shahbano Shakeel, James Z. Zhu, Khushi Ahuja, Lei Guo, et al.CXCL9/MIG Quantikine ELISA Kit (catalog DCX900), the Human CXCL10/IP-10 Quantikine ELISA Kit (catalog DIP100), and the Human CXCL11/I-TAC Quantikine ELISA Kit (catalog DCX110), respectively, according to the manufacturer’s

(4) Cortical organoid-derived models of the melanoma brain metastatic niche enable prioritization of cancer-targeting drugsCell Rep MethodsNovember 14, 2025Krieg K, Materna-Reichelt S, Naber T, Rachad FZ, Kauven P, Weller A, Haferkamp U, Wittich A, Zaliani A, Woo MS, et al.determined using the Human CXCL10/IP10 Quantikine enzyme-linked immunosorbent assay (ELISA) kit (Bio-Techne, DIP100) according to the manufacturer’s instructions. The optical density was measured using the EnVision Multimode

(5) Ubiquitin-specific protease 6 (USP6) mRNA lipid nanoparticles ignite anti-tumor immunity and suppress tumorigenesis in Ewing sarcomaMolecular Cancer TherapeuticsNovember 3, 2025Ian C. Henrich, Margaret M. Billingsley, Kanika Jain, Shreya Mondal, Laura N. Quick, Robert Young, Ngan Nguyen, Andre M. Oliveira, Gerd A. Blobel, Michael J. Mitchell, et al.(for Human CXCL10 (439904) and Human CCL5 (440804)), or R&D Systems (Quantikine Human CXCL10/IP-10 (DIP100)), per manufacturer instructions. Ionizable Lipid Synthesis and LNP Formulation The epoxide terminated

(6) The type 1 diabetes candidate genes PTPN2 and BACH2 regulate the IFN-α-induced crosstalk between JAK/STAT and MAPKs pathways in human beta cellsEBioMedicineOctober 1, 2025Roca-Rivada A, Oliveira JG, Martin-Vazquez E, Coomans de Brachène A, Yi X, Costa-Júnior JM, Zimath PL, Van Goethem F, Pattou F, Kerr-Conte J, et al.

(7) Human cytomegalovirus long non-coding RNA counteracts nuclear cGAS to facilitate immune evasionNature microbiologySeptember 1, 2025Lee S, Kim S, Kim H, Lee D, Jeong D, Kim H, Park J, Park K, Hur J, Kim S, et al.

(8) YAP as a therapeutic target to reverse trastuzumab resistanceGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer AssociationSeptember 1, 2025Nam AR, Oh KS, Bang JH, Jeong Y, Choo SY, Kim HJ, Lee SI, Kim JM, Yoon J, Kim TY, et al.Human CCL5/RANTES Quantikine ELISA Kit (R&D Systems, #DRN00B), Human CXCL10/IP-10 Quantikine ELISA Kit (R&D Systems, #DIP100), and Human HMGB1 ELISA Kit (Assay Genie, #HUFI00660). All procedures were performed according to the

(9) Addressing neuroinflammation in human induced pluripotent stem cell-derived central nervous system neurospheroidsiScienceAugust 5, 2025Catarina M. Gomes, Daniel Simão, Carolina Cardoso Gonçalves, Gabriela Silva, Beatriz Painho, Paula Marques Alves, Catarina Britoin liquid nitrogen, and stored at –80 °C. Human CXCL8 (D8000C), IL-6 (D6050), CCL5 (DRN00B), CXCL10 (DIP100) and CCL2 (DCP00) Quantikine ELISA Kits from R&D Systems were used according to the manufacturer protocol.

(10) Differential immune- and apoptosis-related gene signatures in pancreatic alpha and beta cells contribute to their fate in type 1 diabetesbioRxiv : the preprint server for biologyJuly 31, 2025Yi X, Martin-Vazquez E, Jawurek S, Zimath PL, Oliveira JG, Costa-Junior JM, Ilegems E, Wesley JD, Title AC, Yesildag B, et al.

(11) Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platformCell Reports MedicineJuly 15, 2025Yuqing Zhang, Zehua Li, Jessica Ritter, Elliott J. Brea, Navin R. Mahadevan, Deborah A. Dillon, Sung-Rye Park, Eric Minwei Liu, Michael Y. Tolstorukov, William E. McGourty, et al.Human Cytokine/Chemokine Magnetic Bead Panel,Merck Millipore,Cat# HCYTMAG-60K-PX30 Human CXCL10 ELISA kit,R&D Systems,Cat# DIP100 Human CCL5 ELISA kit,R&D Systems,Cat# DRN00B Human IL-6 ELISA kit,R&D Systems,Cat# D6050 Human IL-8

(12) Daurisoline modulates the TBK1-dependent type I interferon pathway to boost anti-tumor immunity via targeting of LRP1Research (Wash D C)July 4, 2025Borui Tang, Yuting Wang, Liping Li, Cuicui Sun, Jingwen Dong, Ruoqi Li, Jianfeng Wang, Yu Long, Mingxiao Yin, Fei Xie, et al.IFN-β and CXCL10 in cell culture supernatants were measured by ELISA kits (R&D Systems, DIFNB0, MIFNB0, DIP100, and DY466-05) as directed by the manufacturer. IB was performed as described before [30]. Cell viability assay

(13) Novel Quaternary Ammonium Salt‐Linked STING Agonist Antibody‐Drug Conjugate: Synergistic Activation of Tumor Immunity with Mitigated Off‐Target ToxicityAdvanced ScienceJune 10, 2025Yu Long, Borui Tang, Fei Xie, Lianqi Liu, Yangyihua Zhou, Jingwen Dong, Jianfeng Wang, Cuicui Sun, Yuting Wang, Ruoqi Li, et al.TNF‐α in the culture medium were quantified by DuoSet ELISA kits from R&D Systems (Cat# DIFNB0, MIFNB0, DIP100, DY466‐05, MTA00B, DTA00D, and D6050B, respectively). The dose‐response curves were generated using

(14) Long-term pulmonary sequelae and convalescent immune reactions in mild to moderate COVID-19 patients during the active treatment eraPLoS OneJune 5, 2025Minkyeong Lee, Byoung Kwon Park, Dong Hoon Shin, Hong Sang Oh, Chae-Hong Jeong, So-Young Lee, Jungyeon Kim, Sang-Won ParkC-X-C Motif Chemokine Ligand 10/Interferon-gamma-inducible protein 10 (CXCL10/IP-10; R&D systems, #DIP100, Minneapolis, MN, USA), were evaluated using commercially available ELISA kits according to the manufacturer’s

(15) RNA sensing induced by chromosome missegregation augments anti-tumor immunityMolecular CellFebruary 20, 2025Nobunari Sasaki, Mizuki Homme, Takahiko Murayama, Tatsuya Osaki, Toshiyuki Tenma, Tadaichi An, Yujiro Takegami, Tetsuo Tani, Patrick C. Gedeon, Yoshihisa Kobayashi, et al.ImageJ software. ELISA Human IFN-β (R&D systems, Cat.# DIF50C), human CXCL10 (R&D systems, Cat.# DIP100), human Granzyme B (R&D systems, Cat.# DGZB00), mouse IFN-β (R&D systems, Cat.# MIF00), mouse CXCL10

(16) Enhanced therapeutic efficacy of anti-PD-1 blockade by targeting LAMP2A inhibits lysosomal degradation of STING and TBK1TheranosticsFebruary 18, 2025Xueying Wang, Diekuo Zhang, Jiaqing Xiao, Lei Wang, Junrong Wang, Xiaoqiao Cui, Jiaqi Tan, Yong Liu, Susheng Miaosupplemented with 10% fetal bovine serum. Elisa ELISA assays for Human IFN-β (QK410), Human CXCL10 (DIP100), Mouse IFN-β (MIFNB0), and Mouse CXCL10 (MCX100), all from R&D Systems, were conducted adhering strictly

(17) PARP inhibitors differentially regulate immune responses in distinct genetic backgrounds of high-grade serous tubo-ovarian carcinoma modelsCancer Research CommunicationsFebruary 1, 2025Luiza Doro Pereira, Monica Wielgos-Bonvallet, Selim Misirlioglu, Alireza Khodadadi-Jamayran, Petar Jelinic, Douglas A. Levinefor 10 minutes, and stored at −80°C until use. Secreted IL-8 (catalog #D8000C) and IP-10 (catalog #DIP100) were quantified using Human Quantikine enzyme-linked immunosorbent assay (ELISA) kits from R&D Systems. Statistical

(18) Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumoursNatureJanuary 1, 2025Melero I, de Miguel Luken M, de Velasco G, Garralda E, Martín-Liberal J, Joerger M, Alonso G, Goebeler ME, Schuler M, König D, et al.human CXCL9/MIG Quantikine ELISA kit, catalogue no. DCX900; human CXCL10/IP10 Quantikine ELISA kit, catalogue no. DIP100). Both assays were conducted in compliance with the Principles of Good Laboratory Practices regulations. Measurement

(19) JPI-547, a Dual Inhibitor of PARP/Tankyrase, Shows Antitumor Activity Against Pancreatic Cancers with Homologous Recombination Repair Deficiency or Wnt-AddictionInternational journal of biological sciencesJanuary 1, 2025Oh KS, Nam AR, Bang JH, Jeong Y, Choo SY, Kim HJ, Lee SI, Kim JM, Yoon J, Kim TY, et al.Human CCL5/RANTES Quantikine ELISA Kit (#DRN00B; R&D Systems) and Human CXCL10/IP-10 Quantikine ELISA Kit (#DIP100; R&D Systems), following the manufacturer's instructions. Measurement of serum 2′3′-cGAMP levels Serum

(20) Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancerCell reports. MedicineDecember 17, 2024Chakraborty S, Sen U, Ventura K, Jethalia V, Coleman C, Sridhar S, Banerjee A, Ozakinci H, Mahendravarman Y, Snioch K, et al.,R&D Systems,Cat# DIFNB0 CCL5 (Human) ELISA Kit,R&D Systems,Cat# DRN00B CXCL10 (Human) ELISA Kit,R&D Systems,Cat# DIP100 IFNα (mice) ELISA Kit,R&D Systems,Cat# MFNAS0 IFNβ (mice) ELISA Kit,R&D Systems,Cat# MIFNB0 CCL5

Be the First to Write a Review!

CXCL10/IP-10/CRG-2 ELISA

CXCL10/IP-10/CRG-2 ELISA

CXCL10/IP-10/CRG-2 ELISA

Human CXCL10/IP-10 Quantikine ELISA Kit from R&D Systems, a Bio-Techne Brand

Description

R&D Systems, a Bio-Techne Brand

Citations (217)

Reviews

Human CXCL10/IP-10 Quantikine ELISA Kit from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map